A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis

A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis

Purpose: Total knee arthroplasty (TKA) and total hip arthroplasty (THA) patients are at an elevated risk of post-operative venous thromboembolism (VTE). Newer thromboprophylactic agents such as rivaroxaban are increasingly used and effective in preventing thromboembolic events but may worsen bleedin...

Full description

Bibliographic Details
Main Authors:	Joshua Xu, Aran Kanagaratnam, Jacob Y Cao, Gurpreet S Chaggar, Warwick Bruce
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-01-01
Series:	Journal of Orthopaedic Surgery
Online Access:	https://doi.org/10.1177/2309499019896024

Similar Items

Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban
by: Jose Luiz Colleoni, et al.

Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification
by: Kenneth M. Vaz, MD, et al.
Published: (2020-06-01)

Pulmonary Embolism While on Aspirin for Venous Thromboembolism Prophylaxis After Total Knee Arthroplasty
by: Francisco Roman, et al.
Published: (2018-08-01)

An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020
by: Daniel C. Santana, et al.
Published: (2020-08-01)

Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial
by: Yi Ren, et al.
Published: (2021-01-01)

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 3. Pharmacological venous thromboembolism prophylaxis
by: Satit Thiengwittayaporn, et al.
Published: (2021-08-01)

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery
by: Turpie AG, et al.
Published: (2012-06-01)

Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis
by: Bangsheng Hu, et al.
Published: (2021-02-01)

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis
by: Chavarin Amarase, et al.
Published: (2021-06-01)

Prevention of Venous Thromboembolism in Hip and Knee Arthroplasty
by: Mario Ponikvar, et al.
Published: (2010-03-01)

Multimodal Venous Thromboembolism Thrombophilia Screening Examinations for Prophylaxis with Preoperative Total Hip and Knee Arthroplasties
by: Yasushi Oshima, MD, PhD, et al.
Published: (2015-12-01)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
by: Levitan B, et al.
Published: (2014-03-01)

Pharmacologic Prophylaxis and Treatment of Venous Thromboembolism after Knee Arthroplasty
by: Jamal S Shawabkeh, et al.
Published: (2007-04-01)

Should prophylaxis of venous thromboembolism in Asian patients undergoing knee and hip arthroplasty and hip fracture surgery be an issue?
by: Aree Tanavalee
Published: (2021-07-01)

Venous Thromboembolism Prophylaxis with Rivaroxaban in Elective Foot and Ankle Surgery
by: Martin J. Wiewiorski MD, et al.
Published: (2016-08-01)

Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin
by: Wael A. Rahman, et al.
Published: (2020-07-01)

Venous thromboembolism rates after hip and knee arthroplasty and hip fractures
by: Viswanath Mula, et al.
Published: (2020-02-01)

Time for an Update? A Look at Current Guidelines for Venous Thromboembolism Prophylaxis After Hip and Knee Arthroplasty and Hip Fracture
by: Stefano R. Muscatelli, MD, et al.
Published: (2021-08-01)

Safety of Peri-Operative Low-Dose Aspirin as a Part of Multimodal Venous Thromboembolic Prophylaxis for Total Knee and Hip Arthoplasty
by: David J Cossetto, et al.
Published: (2012-12-01)

Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery
by: Qiang Huang, et al.
Published: (2019-10-01)

A study of antithrombotic agent, rivaroxaban, in preventing venous thromboembolism after hip and knee replacement surgery
by: Yun-Chuan Mao, et al.
Published: (2014)

Pharmacoeconomic study on rivaroxaban vs conventional venous thromboembolism prophylaxis following elective total hip or knee replacement surgery in Serbia: Single centre study
by: Perović Saša R., et al.
Published: (2017-01-01)

Increased incidence of venous thromboembolism following hip or knee arthroplasty in winter
by: Christopher Wynne Jones, et al.
Published: (2020-04-01)

Quality appraisal of clinical guidelines for venous thromboembolism prophylaxis in patients undergoing hip and knee arthroplasty: a systematic review
by: Dong Pang, et al.
Published: (2020-12-01)

Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
by: Kwong LM
Published: (2013-08-01)

Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
by: Kochawan Boonyawat, et al.
Published: (2021-02-01)

Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data
by: Kwong LM
Published: (2011-07-01)

Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain
by: Xavier Granero Xiberta, et al.

CRISTAL (a cluster-randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study): statistical analysis plan
by: Verinder Singh Sidhu, et al.
Published: (2021-08-01)

Cost-Effectiveness of Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Adult Patients Undergoing Elective Hip or Knee Replacement Surgery in Portugal
by: José Roxo Neves, et al.
Published: (2014-01-01)

Chemoprophylaxis in addition to mechanical prophylaxis after total knee arthroplasty surgery does not reduce the incidence of venous thromboembolism
by: Jing Loong Moses Loh, et al.
Published: (2019-06-01)

Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
by: Antonijević Nebojša, et al.
Published: (2020-01-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)

Risk‐Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis
by: Hui‐ming Peng, et al.
Published: (2021-02-01)

Prophylaxis of venous thromboembolism – The guidelines are there
by: Paulo Pinho
Published: (2017-09-01)

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 1. Diagnosis and risk factors
by: Srihatach Ngarmukos, et al.
Published: (2021-06-01)

Rivaroxaban in preventing venous thromboembolism after arthroplastic surgery in Taiwan
by: Yun-Chuan Mao, et al.
Published: (2015-10-01)

Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
by: M Stevenson, et al.
Published: (2009-10-01)